Trial intelligence / Profile preview

AzaSite Pilot in Posterior Blepharitis

NCT00629590Phase 4Completed

Sponsor
Merck & Co.
Start
Mar 2008
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of AzaSite in posterior blepharitis, sponsored by Merck & Co.. Started Mar 2008; status: completed.

02

Drugs

AzaSite
03

Conditions

posterior blepharitis

Beyond the preview

Go deeper on NCT00629590.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00629590.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call